CORMEDIX INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CORMEDIX INC. stock issued during period, value, other for the quarter ending 2023-12-31 was $0.00.
- CORMEDIX INC. stock issued during period, value, other for the quarter ending 2023-09-30 was $42.88M.
- CORMEDIX INC. stock issued during period, value, other for the quarter ending 2020-06-30 was $0.00.
- CORMEDIX INC. stock issued during period, value, other for the quarter ending 2020-03-31 was $325.00K.
- CORMEDIX INC. stock issued during period, value, other for fiscal 2023 was $42.88M.
- CORMEDIX INC. stock issued during period, value, other for fiscal 2018 was $173.77K.
- CORMEDIX INC. stock issued during period, value, other for fiscal 2008 was $328.95K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $42.88M 10-K · filed 2025-03-25 |
| 2023-09-30 | $42.88M 10-Q · filed 2024-10-30 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2020-03-31 | $325.00K 10-Q · filed 2020-05-11 | |
| 2019-09-30 | $100.00 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $173.77K 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2018-03-31 | $173.77K 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | |
| 2017-03-31 | $10.22K 10-Q · filed 2017-05-10 | |
| 2008-12-31 | $328.95K 10-K · filed 2013-03-27 | |
| 2007-03-31 | $212.00 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |